{"entity":{"type":"insider","cik":"0001292358","url":"/insider/0001292358","json_url":"/insider/0001292358.json","name":"Atlas Venture Fund VI GmbH & Co KG","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":50,"n_filings":9,"first":"2004-06-02","last":"2012-03-06","span_basis":"filed_date"},"name_variants":[{"name":"Atlas Venture Fund VI GmbH & Co KG","source":"filing","n_filings":9,"first_seen":"2004-06-02","last_seen":"2012-03-06"}],"transactions":[{"id":3364740,"accession":"0001104659-12-015909","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-12-015909","line_url":"/filing/0001104659-12-015909#line-1","is_derivative":false,"issuer_cik":"0001136148","issuer_name":"HORIZON PHARMA, INC.","issuer_ticker":"HZNP","issuer_name_source":null,"issuer_url":"/issuer/0001136148","owner_cik":null,"owner_name":"Atlas Venture Associates VI, L.P.; Atlas Venture Fund VI GmbH & Co KG; ATLAS VENTURE ENTREPRENEURS FUND VI LP; ATLAS VENTURE FUND VI LP","owner_display_name":"Atlas Venture Associates VI, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":828443.0,"shares_display":"828,443","price_per_share":3.6212,"price_display":"3.62","price_state":"stated","total_value":2999957.7916,"total_display":"2,999,957.79","total_whole":"2,999,958","shares_owned_after":3688294.0,"shares_owned_after_display":"3,688,294","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-03-02","filed_date":"2012-03-06","scope":"insider"},{"id":8853275,"accession":"0001209191-11-042498","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-11-042498","line_url":"/filing/0001209191-11-042498","is_derivative":false,"issuer_cik":"0001136148","issuer_name":"HORIZON PHARMA, INC.","issuer_ticker":"HZNP","issuer_name_source":null,"issuer_url":"/issuer/0001136148","owner_cik":null,"owner_name":"Atlas Venture Associates VI, Inc; Atlas Venture Fund VI GmbH & Co KG; ATLAS VENTURE FUND VI LP; ATLAS VENTURE ENTREPRENEURS FUND VI LP","owner_display_name":"Atlas Venture Associates VI, Inc","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":369814.0,"shares_display":"369,814","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":3328326.0,"total_display":"3,328,326.00","total_whole":"3,328,326","shares_owned_after":2516089.0,"shares_owned_after_display":"2,516,089","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-08-02","filed_date":"2011-08-04","scope":"insider","n_lines":3},{"id":5854848,"accession":"0001104659-09-055721","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-09-055721","line_url":"/filing/0001104659-09-055721#line-1","is_derivative":false,"issuer_cik":"0001106910","issuer_name":"HELICOS BIOSCIENCES CORP","issuer_ticker":"HLCS","issuer_name_source":null,"issuer_url":"/issuer/0001106910","owner_cik":null,"owner_name":"ATLAS VENTURE ASSOCIATES V LP; Atlas Venture Fund VI GmbH & Co KG; ATLAS VENTURE FUND V LP; Atlas Venture Associates VI, L.P.; ATLAS VENTURE FUND VI LP; ATLAS VENTURE ENTREPRENEURS FUND VI LP; ATLAS VENTURE ENTREPRENEURS FUND V LP","owner_display_name":"ATLAS VENTURE ASSOCIATES V LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Ccmmon Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":242931.0,"shares_display":"242,931","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":11851387.0,"shares_owned_after_display":"11,851,387","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-09-18","filed_date":"2009-09-22","scope":"insider"},{"id":3514896,"accession":"0001179110-08-021567","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-08-021567","line_url":"/filing/0001179110-08-021567#line-1","is_derivative":false,"issuer_cik":"0001106910","issuer_name":"HELICOS BIOSCIENCES CORP","issuer_ticker":"HLCS","issuer_name_source":null,"issuer_url":"/issuer/0001106910","owner_cik":null,"owner_name":"ATLAS VENTURE ENTREPRENEURS FUND V LP; ATLAS VENTURE FUND VI LP; ATLAS VENTURE FUND V LP; Atlas Venture Associates VI, L.P.; ATLAS VENTURE ASSOCIATES V LP; ATLAS VENTURE ENTREPRENEURS FUND VI LP; Atlas Venture Fund VI GmbH & Co KG","owner_display_name":"ATLAS VENTURE ENTREPRENEURS FUND V LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8620690.0,"shares_display":"8,620,690","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":11608456.0,"shares_owned_after_display":"11,608,456","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-23","filed_date":"2008-12-29","scope":"insider"},{"id":7875246,"accession":"0001179110-07-011727","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-07-011727","line_url":"/filing/0001179110-07-011727#line-2","is_derivative":false,"issuer_cik":"0001106910","issuer_name":"HELICOS BIOSCIENCES CORP","issuer_ticker":"HLCS","issuer_name_source":null,"issuer_url":"/issuer/0001106910","owner_cik":null,"owner_name":"ATLAS VENTURE ENTREPRENEURS FUND V LP; ATLAS VENTURE FUND V LP; Atlas Venture Associates VI, L.P.; ATLAS VENTURE FUND VI LP; ATLAS VENTURE ASSOCIATES V LP; Atlas Venture Fund VI GmbH & Co KG; ATLAS VENTURE ENTREPRENEURS FUND VI LP; ATLAS VENTURE PARALLEL FUND V-A C V","owner_display_name":"ATLAS VENTURE ENTREPRENEURS FUND V LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":333333.0,"shares_display":"333,333","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":2999997.0,"total_display":"2,999,997.00","total_whole":"2,999,997","shares_owned_after":2987766.0,"shares_owned_after_display":"2,987,766","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-05-30","filed_date":"2007-05-31","scope":"insider"},{"id":5511160,"accession":"0001209191-06-013540","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001209191-06-013540","line_url":"/filing/0001209191-06-013540","is_derivative":false,"issuer_cik":"0001106910","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001106910","owner_cik":null,"owner_name":"ATLAS VENTURE FUND VI LP; ATLAS VENTURE PARALLEL FUND V-A C V; ATLAS VENTURE ENTREPRENEURS FUND VI LP; ATLAS VENTURE ASSOCIATES V LP; Atlas Venture Fund VI GmbH & Co KG; ATLAS VENTURE ENTREPRENEURS FUND V LP; ATLAS VENTURE FUND V LP; Atlas Venture Associates VI, L.P.","owner_display_name":"ATLAS VENTURE FUND VI LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":120000.0,"shares_display":"120,000","price_per_share":14.797,"price_display":"14.80","price_state":"stated","total_value":1775640.0,"total_display":"1,775,640.00","total_whole":"1,775,640","shares_owned_after":747580.0,"shares_owned_after_display":"747,580","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-02-24","filed_date":"2006-02-27","scope":"insider","n_lines":8},{"id":5511139,"accession":"0001209191-06-013540","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-06-013540","line_url":"/filing/0001209191-06-013540","is_derivative":false,"issuer_cik":"0001106910","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001106910","owner_cik":null,"owner_name":"ATLAS VENTURE FUND VI LP; ATLAS VENTURE PARALLEL FUND V-A C V; ATLAS VENTURE ENTREPRENEURS FUND VI LP; ATLAS VENTURE ASSOCIATES V LP; Atlas Venture Fund VI GmbH & Co KG; ATLAS VENTURE ENTREPRENEURS FUND V LP; ATLAS VENTURE FUND V LP; Atlas Venture Associates VI, L.P.","owner_display_name":"ATLAS VENTURE FUND VI LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63000.0,"shares_display":"63,000","price_per_share":15.1416,"price_display":"15.14","price_state":"stated","total_value":953920.8,"total_display":"953,920.80","total_whole":"953,921","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-02-23","filed_date":"2006-02-27","scope":"insider","n_lines":8},{"id":318441,"accession":"0001104659-04-017813","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001104659-04-017813","line_url":"/filing/0001104659-04-017813","is_derivative":false,"issuer_cik":"0001106910","issuer_name":"MOMENTA PHARMACEUTICALS INC","issuer_ticker":"MNTA","issuer_name_source":null,"issuer_url":"/issuer/0001106910","owner_cik":null,"owner_name":"ATLAS VENTURE PARALLEL FUND V-B C V; ATLAS VENTURE FUND V LP; Atlas Venture Associates VI, L.P.; ATLAS VENTURE ENTREPRENEURS FUND V LP; ATLAS VENTURE FUND VI LP; ATLAS VENTURE ENTREPRENEURS FUND VI LP; ATLAS VENTURE PARALLEL FUND V-A C V; ATLAS VENTURE ASSOCIATES V LP; Atlas Venture Fund VI GmbH & Co KG","owner_display_name":"ATLAS VENTURE PARALLEL FUND V-B C V","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":244000.0,"shares_display":"244,000","price_per_share":6.5,"price_display":"6.50","price_state":"stated","total_value":1586000.0,"total_display":"1,586,000.00","total_whole":"1,586,000","shares_owned_after":73201.0,"shares_owned_after_display":"73,201","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-06-21","filed_date":"2004-06-24","scope":"insider","n_lines":9},{"id":591996,"accession":"0001209191-04-029066","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-04-029066","line_url":"/filing/0001209191-04-029066#line-9","is_derivative":false,"issuer_cik":"0001106910","issuer_name":"ALNYLAM PHARMACEUTICALS INC","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001106910","owner_cik":null,"owner_name":"ATLAS VENTURE PARALLEL FUND V-A C V; ATLAS VENTURE PARALLEL FUND V-B C V; ATLAS VENTURE ASSOCIATES V LP; ATLAS VENTURE ENTREPRENEURS FUND VI LP; ATLAS VENTURE FUND V LP; Atlas Venture Associates VI, L.P.; ATLAS VENTURE FUND VI LP; Atlas Venture Fund VI GmbH & Co KG; ATLAS VENTURE ENTREPRENEURS FUND V LP","owner_display_name":"ATLAS VENTURE PARALLEL FUND V-A C V","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":127767.0,"shares_display":"127,767","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":766602.0,"total_display":"766,602.00","total_whole":"766,602","shares_owned_after":127767.0,"shares_owned_after_display":"127,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-06-01","filed_date":"2004-06-02","scope":"insider"},{"id":9258506,"accession":"0001209191-04-030076","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-04-030076","line_url":"/filing/0001209191-04-030076","is_derivative":false,"issuer_cik":"0001292359","issuer_name":"ALNYLAM PHARMACEUTICALS INC","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001292359","owner_cik":null,"owner_name":"ATLAS VENTURE ASSOCIATES V LP; ATLAS VENTURE ENTREPRENEURS FUND V LP; ATLAS VENTURE ENTREPRENEURS FUND VI LP; ATLAS VENTURE FUND V LP; ATLAS VENTURE FUND VI LP; ATLAS VENTURE PARALLEL FUND V-A C V; ATLAS VENTURE PARALLEL FUND V-B C V; Atlas Venture Associates VI, L.P.; Atlas Venture Fund VI GmbH & Co KG","owner_display_name":"ATLAS VENTURE ASSOCIATES V LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":445000.0,"shares_display":"445,000","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":2670000.0,"total_display":"2,670,000.00","total_whole":"2,670,000","shares_owned_after":133501.0,"shares_owned_after_display":"133,501","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-05-27","filed_date":"2004-06-07","scope":"insider","n_lines":9},{"id":591995,"accession":"0001209191-04-029066","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-04-029066","line_url":"/filing/0001209191-04-029066","is_derivative":false,"issuer_cik":"0001106910","issuer_name":"ALNYLAM PHARMACEUTICALS INC","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001106910","owner_cik":null,"owner_name":"ATLAS VENTURE PARALLEL FUND V-A C V; ATLAS VENTURE PARALLEL FUND V-B C V; ATLAS VENTURE ASSOCIATES V LP; ATLAS VENTURE ENTREPRENEURS FUND VI LP; ATLAS VENTURE FUND V LP; Atlas Venture Associates VI, L.P.; ATLAS VENTURE FUND VI LP; Atlas Venture Fund VI GmbH & Co KG; ATLAS VENTURE ENTREPRENEURS FUND V LP","owner_display_name":"ATLAS VENTURE PARALLEL FUND V-A C V","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":317233.0,"shares_display":"317,233","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":1903398.0,"total_display":"1,903,398.00","total_whole":"1,903,398","shares_owned_after":133501.0,"shares_owned_after_display":"133,501","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-05-27","filed_date":"2004-06-02","scope":"insider","n_lines":8}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001492426","name":"HORIZON PHARMA, INC.","url":"/issuer/0001492426","role":"Ten percent owner","n_filings":2,"first_seen":"2011-08-04","last_seen":"2012-03-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001274563","name":"HELICOS BIOSCIENCES CORP","url":"/issuer/0001274563","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2007-05-31","last_seen":"2009-09-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001178670","name":"ALNYLAM PHARMACEUTICALS, INC.","url":"/issuer/0001178670","role":"Ten percent owner","n_filings":3,"first_seen":"2004-06-02","last_seen":"2006-02-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001235010","name":"MOMENTA PHARMACEUTICALS INC","url":"/issuer/0001235010","role":"Ten percent owner","n_filings":1,"first_seen":"2004-06-24","last_seen":"2004-06-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001292358","retrieved_at":"2026-08-24T02:02:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}